Terms: = Colorectal cancer AND SETBP1, Q9UEF3, Q6P6C3, A6H8W5, Q9Y6X0, 26040, SEB, KIAA0437, ENSG00000152217
14 results:
1. Transient receptor potential channel stimulation induced oxidative stress and apoptosis in the colon of mice with colitis-associated colon cancer: modulator role of Sambucus ebulus L.
Kaya MM; Kaya İ; Nazıroğlu M
Mol Biol Rep; 2023 Mar; 50(3):2207-2220. PubMed ID: 36565417
[TBL] [Abstract] [Full Text] [Related]
2. Growth-inhibitory effects of TGFαL3-seb chimeric protein on colon cancer cell line.
Maleki F; Sadeghifard N; Hosseini HM; Bakhtiyari S; Goleij Z; Behzadi E; Sedighian H; Imani Fooladi AA
Biomed Pharmacother; 2019 Feb; 110():190-196. PubMed ID: 30471512
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of Potential Alterations Affecting setbp1 as a Novel Contributing Mechanism to Inhibit PP2A in colorectal cancer Patients.
Torrejón B; Cristóbal I; Caramés C; Prieto-Potín I; Chamizo C; Santos A; Sanz-Alvarez M; Serna-Blasco R; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
World J Surg; 2018 Nov; 42(11):3771-3778. PubMed ID: 29796729
[TBL] [Abstract] [Full Text] [Related]
4. Modulation of transforming growth factor‑β signaling transducers in colon adenocarcinoma cells induced by staphylococcal enterotoxin B.
Akbari A; Mobini GR; Maghsoudi R; Akhtari J; Faghihloo E; Farahnejad Z
Mol Med Rep; 2016 Jan; 13(1):909-14. PubMed ID: 26647993
[TBL] [Abstract] [Full Text] [Related]
5. Growth inhibition and antioxidative status induced by selenium-enriched broccoli extract and selenocompounds in DNA mismatch repair-deficient human colon cancer cells.
Tsai CF; Ou BR; Liang YC; Yeh JY
Food Chem; 2013 Aug; 139(1-4):267-73. PubMed ID: 23561105
[TBL] [Abstract] [Full Text] [Related]
6. Construction and characterization of a novel superantigen fusion protein: bFGF/seb.
Wang L; Zhang H; Zhang S; Yu M; Yang X
Cancer Invest; 2009 May; 27(4):376-83. PubMed ID: 19160106
[TBL] [Abstract] [Full Text] [Related]
7. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract] [Full Text] [Related]
8. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.
Einspahr JG; Alberts DS; Gapstur SM; Bostick RM; Emerson SS; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):37-48. PubMed ID: 8993796
[TBL] [Abstract] [Full Text] [Related]
9. The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant.
Abdalla EE; Adam IJ; Blair GE; Boylston A; Sue-Ling HM; Finan P; Johnston D
Cancer Immunol Immunother; 1995 Sep; 41(3):193-8. PubMed ID: 7553689
[TBL] [Abstract] [Full Text] [Related]
10. Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.
Bateman WJ; Donnellan I; Fraser IA; Wong LS; Morris AG
Cancer Immunol Immunother; 1995 Jul; 41(1):61-7. PubMed ID: 7641220
[TBL] [Abstract] [Full Text] [Related]
11. Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to seb but not to SEA.
Maeurer M; Zitvogel L; Elder E; Storkus WJ; Lotze MT
Nat Immun; 1995 Apr; 14(4):188-97. PubMed ID: 8696008
[TBL] [Abstract] [Full Text] [Related]
12. Surrogate endpoint biomarker assays in phase II chemoprevention clinical trials.
Lipkin M; Bhandari M; Hakissian M; Croll W; Wong G
J Cell Biochem Suppl; 1994; 19():47-54. PubMed ID: 7823605
[TBL] [Abstract] [Full Text] [Related]
13. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract] [Full Text] [Related]
14. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
[TBL] [Abstract] [Full Text] [Related]
